Lyme neuroborreliosis in children: A prospective study of clinical features, prognosis, and outcome

Pediatric Infectious Disease Journal

Volumn 27, Issue 12, 2008, Pages 1089-1094

  Skogman, Barbro Hedin ^a,b   Croner, Stefan ^a   Nordwall, Maria ^c   Eknefelt, Mattias ^d   Ernerudh, Jan ^e   Forsberg, Pia ^f  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Center for Clinical Research Dalarna   (Sweden)

^c Pediatric Clinic   (Sweden)

^d Pediatric Clinic   (Sweden)

^e Division of Clinical Immunology   (Sweden)

^f Division of Infectious Diseases   (Sweden)

Author keywords

children; clinical outcome; Lyme disease; neuroborreliosis; prognostic factors; prospective

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G; ANTIINFECTIVE AGENT; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLEOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SWEDEN; SYMPTOMATOLOGY; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LEUKOCYTOSIS; NONPARAMETRIC TEST; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACIAL PARALYSIS; FEMALE; HUMANS; IMMUNOGLOBULIN M; LEUKOCYTOSIS; LYME NEUROBORRELIOSIS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SWEDEN; TREATMENT OUTCOME;

EID: 58149377375     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31817fd423     Document Type: Article

References (60)

1. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639-1647.
2. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-596.
3. Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, P?ughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245:262-272.
4. Christen HJ. Lyme neuroborreliosis in children. Ann Med. 1996;28:235- 240.
5. Bingham PM, Galetta SL, Athreya B, Sladky J. Neurologic manifestations in children with Lyme disease. Pediatrics. 1995;96:1053-1056.
6. Sood SK. Lyme disease. Pediatr Infect Dis J. 1999;18:913-925.
7. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skö ldenberg B. Clinical manifestations and diagnosis of neuroborreliosis. AnnNY Acad Sci. 1988;539:46-55.
8. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl. 1993;386:1-75.
9. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-1327.
10. Belman AL, Eitrem R, Ornstein K, et al. Neurologic manifestations in children with North American Lyme disease. Neurology. 1993;43:2609- 2614.
11. Millner MM, Mü llegger RR, Spork KD, Stanek G. Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge. Infection. 1991;19:273-278.
12. Tveitnes D, Oymar K, Natas O. Acute facial nerve palsy in children: how often is it lyme borreliosis? Scand J Infect Dis. 2007;39:425-431.
13. Eppes SC. Diagnosis, treatment, and prevention of Lyme disease in children. Paediatr Drugs. 2003;5:363-372.
14. Vukelic D, Bozinovic D, Morovic M, et al. Opsoclonus-myoclonus syndrome in a child with neuroborreliosis. J Infect. 2000;40:189-191.
15. Ylitalo V, Hagberg BA. Progressive ataxia in Swedish children: a re-evaluation study. Acta Neurol Scand. 1994;89:299-302.
16. Peltomaa M, Pyykkö I, Seppälä I, Viljanen M. Lyme borreliosis-an unusual cause of vertigo. Auris Nasus Larynx. 1998;25:233-242.
17. Muller D, Neubauer BA, Waltz S, Stephani U. Neuroborreliosis and isolated trochlear palsy. Eur J Paediatr Neurol. 1998;2:275-276.
18. Huisman TA, Wohlrab G, Nadal D, Boltshauser E, Martin E. Unusual presentations of neuroborreliosis (Lyme disease) in childhood. J Comput Assist Tomogr. 1999;23:39-42.
19. Wilke M, Eiffert H, Christen HJ, Hanefeld F. Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review. Arch Dis Child. 2000;83:67-71.
20. Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998;18:439-441.
21. Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol. 1996;34:2343-2350.
22. van Dam AP. Recent advances in the diagnosis of Lyme disease. Expert Rev Mol Diagn. 2001;1:413-427.
23. Wilske B. Diagnosis of lyme borreliosis in europe. Vector Borne Zoonotic Dis. 2003;3:215-227.
24. Brouqui P, Bacellar F, Baranton G, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10: 1108-1132.
25. Stanek G, O'Connell S, Cimmino M, et al. European union concerted action on risk assessment in Lyme borreliosis: clinical case de?nitions for Lyme borreliosis. Wien Klin Wochenschr. 1996;108:741-747.
26. Brown SL, Hansen SL, Langone JJ. Role of serology in the diagnosis of Lyme disease. JAMA. 1999;282:62-66.
27. Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am. 2002;86:311-340.
28. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1109-1123.
29. Hansen K. Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-1990. Acta Neurol Scand Suppl. 1994;151:1-44.
30. Ekerfelt C, Forsberg P, Svenvik M, Roberg M, Bergström S, Ernerudh J. Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-speci?c interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection. Clin Exp Immunol. 1999;115:498-502.
31. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis. 2002;34:421-425.
32. Peltomaa M, Saxen H, Seppälä I, Viljanen M, Pyykkö I. Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. Scand J Infect Dis. 1998;30:269-275.
33. Skogman BH, Croner S, Odkvist L. Acute facial palsy in children-a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol. 2003;67:597-602.
34. Vazquez M, Sparrow SS, Shapiro ED. Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics. 2003;112:e93-e97.
35. Adams WV, Rose CD, Eppes SC, Klein JD. Long-term cognitive effects of Lyme disease in children. Appl Neuropsychol. 1999;6:39-45.
36. Wang TJ, Sangha O, Phillips CB, et al. Outcomes of children treated for Lyme disease. J Rheumatol. 1998;25:2249-2253.
37. Shadick NA, Phillips CB, Sangha O, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med. 1994;121:560-567.
38. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005;34:1340-1345.
39. Halperin JJ. Prolonged Lyme disease treatment. Neurology. 2008;70: 986-987.
40. Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis. 2001;20:6-13.
41. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91-102.
42. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93:146-147.
43. Tuerlinckx D, Bodart E, Garrino MG, de Bilderling G. Clinical data and cerebrospinal ?uid ?ndings in Lyme meningitis versus aseptic menin- gitis. Eur J Pediatr. 2003;162:150-153.
44. Hansen K, Pii K, Lebech AM. Improved immunoglobulin M serodiag- nosis in Lyme borreliosis by using a mu-capture enzyme-linked immu- nosorbent assay with biotinylated Borrelia burgdorferi ?agella. J Clin Microbiol. 1991;29:166-173.
45. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diag- nostic assay for intrathecal synthesis of Borrelia burgdorferi-speci?c immunoglobulin G A and M. Ann Neurol. 1991;30:197-205.
46. MPA. Treatment and prevention of tick borne infections. Medical Products Agency (MPA). 1998;2:38-39.
47. Thorstrand C, Belfrage E, Bennet R, Malmborg P, Eriksson M. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002;21:1142-1145.
48. Laurell K, Larsson B, Mattsson P, Eeg-Olofsson O. A 3-year follow-up of headache diagnoses and symptoms in Swedish schoolchildren. Ceph- alalgia. 2006;26:809-815.
49. Rastad C, Ulfberg J, Sjoden PO. High prevalence of self-reported depressive mood during the winter season among Swedish senior high school students. J Am Acad Child Adolesc Psychiatry. 2006;45:231-238.
50. Bagger-Sjoback D, Remahl S, Ericsson M. Long-term outcome of facial palsy in neuroborreliosis. Otol Neurotol. 2005;26:790-795.
51. Qureshi MZ, New D, Zulqarni NJ, Nachman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J. 2002; 21:12-14.
52. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Ann Med. 2005;37:568-579.
53. Shah SS, Zaoutis TE, Turnquist J, Hodinka RL, Cof?n SE. Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J. 2005;24:542-545.
54. Eppes SC, Nelson DK, Lewis LL, Klein JD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics. 1999;103:957-960.
55. Avery RA, Frank G, Glutting JJ, Eppes SC. Prediction of Lyme men- ingitis in children from a Lyme disease-endemic region: a logistic- regression model using history, physical, and laboratory ?ndings. Pediatrics. 2006;117:e1-e7.
56. Widhe M, Skogman BH, Jarefors S, et al. Up-regulation of Borrelia- speci?c IL-4- and IFN-gamma-secreting cells in cerebrospinal ?uid from children with Lyme neuroborreliosis. Int Immunol. 2005;17:1283-1291.
57. Panelius J, Lahdenne P, Saxén H, et al. Diagnosis of Lyme neurobor- reliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and Vlse IR6 peptide. J Neurol. 2002;250:1318-1327.
58. Skogman BH, Croner S, Forsberg P, et al. Improved laboratory diag- nostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal ?uid. Pediatr Infect Dis J. 2008;27: 605-612.
59. Bennet L, Danell S, Berglund J. Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin. Scand J Infect Dis. 2003;35:129-131.
60. Arnez M. Antibiotic treatment of children with erythema migrans. Clin Infect Dis. 2007;44:1133-1134; author reply 1137-1139.